Sigma sinks despite reporting 36% EBIT growth post-Chemist Warehouse merger
Make us a preferred source
Make us a preferred source on Google
The news: Shares in Sigma Healthcare fell in morning trade after the company provided its first earnings update since its reverse merger with Chemist Warehouse.
The numbers: The company reported unaudited normalised EBIT (which excludes transaction costs) grew 36% on the first half of FY24 to hit $446.1 million in the first half of FY25.
Transaction costs in the third quarter totalled $34.3 million, and $42.4 million across the nine-month period.
Sigma's share price was almost 4% lower at 12.09pm AEST following the release of the figures, as well as the company's presentation to this week's Macquarie Sydney conference.
The context: The newly merged Sigma Healthcare and Chemist Warehouse started trading on the ASX on 13 February after the listed pharmacy wholesaler completed its buyout of the retail chain. Sigma will report its full year results in August.
The source: ASX announcement
